Abstract
Get full access to this article
View all access options for this article.
References
1.
Scolding
N
Barnes
D
Cader
S
. Association of British Neurologists: Revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis . Pract Neurol 2015 ; 15 : 273 –279 .
2.
Cooper
C
Palace
J
Pickin
M
. The multiple sclerosis monitoring study: Progress to date . Proceedings of the association of British Neurologists spring meeting April 2004 . J Neurol Neurosurg Psychiatry 2004 ; 75 : 1213 –1228 .
3.MS 2015 vision – a report from the MS forum 2011 , https://www.mssociety.org.uk/sites/default/files/Documents/Campaigns%20resources/MS%202015%20Vision%20-%20A%20report%20from%20the%20MS%20Forum.pdf
4.A Lottery of Treatment and Care . MS Society report , April 2013 , https://www.mssociety.org.uk/sites/default/files/Documents/Research/A%20lottery%20of%20treatment%20and%20care%20-%20technical%20report.pdf
5.
Turner
AP
Chapko
MK
Yanez
D
. Access to multiple sclerosis specialty care . PM R 2013 ; 5 : 1044 –1050 .
6.House of Commons Committee of Public Accounts Report . Services to people with neurological conditions: progress review enquiry . London : The Stationary Office , http://www.publications.parliament.uk/pa/cm201516/cmselect/cmpubacc/502/502.pdf (accessed 22 February 2016 ).